210 related articles for article (PubMed ID: 1748641)
1. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
Liu LW; Ye J; Johnson AE; Esmon CT
J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
[TBL] [Abstract][Full Text] [Related]
2. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
3. The activation of prothrombin by the prothrombinase complex. The contribution of the substrate-membrane interaction to catalysis.
Walker RK; Krishnaswamy S
J Biol Chem; 1994 Nov; 269(44):27441-50. PubMed ID: 7961657
[TBL] [Abstract][Full Text] [Related]
4. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
5. Progressive development of a thrombin inhibitor binding site.
Hibbard LS; Nesheim ME; Mann KG
Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
[TBL] [Abstract][Full Text] [Related]
6. Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin.
Anderson PJ; Nesset A; Bock PE
J Biol Chem; 2003 Nov; 278(45):44482-8. PubMed ID: 12939269
[TBL] [Abstract][Full Text] [Related]
7. Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin.
Ni F; Ning Q; Jackson CM; Fenton JW
J Biol Chem; 1993 Aug; 268(23):16899-902. PubMed ID: 8349581
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
9. Regions remote from the site of cleavage determine macromolecular substrate recognition by the prothrombinase complex.
Betz A; Krishnaswamy S
J Biol Chem; 1998 Apr; 273(17):10709-18. PubMed ID: 9553135
[TBL] [Abstract][Full Text] [Related]
10. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
11. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
[TBL] [Abstract][Full Text] [Related]
12. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
13. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody.
Wu Q; Picard V; Aiach M; Sadler JE
J Biol Chem; 1994 Feb; 269(5):3725-30. PubMed ID: 8106418
[TBL] [Abstract][Full Text] [Related]
15. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
Kroh HK; Tans G; Nicolaes GA; Rosing J; Bock PE
J Biol Chem; 2007 Jun; 282(22):16095-104. PubMed ID: 17430903
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
Krishnaswamy S; Walker RK
Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
[TBL] [Abstract][Full Text] [Related]
17. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
[TBL] [Abstract][Full Text] [Related]
18. Binding of hirudin to meizothrombin.
Fischer BE; Schlokat U; Himmelspach M; Dorner F
Protein Eng; 1998 Aug; 11(8):715-21. PubMed ID: 9749925
[TBL] [Abstract][Full Text] [Related]
19. Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin.
Stevens WK; Nesheim ME
Biochemistry; 1993 Mar; 32(11):2787-94. PubMed ID: 8457546
[TBL] [Abstract][Full Text] [Related]
20. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid.
Boskovic DS; Giles AR; Nesheim ME
J Biol Chem; 1990 Jun; 265(18):10497-505. PubMed ID: 2355010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
